Liquidia Technologies, Inc. (NASDAQ:LQDA) Receives $32.11 Average PT from Analysts

Key Points

• Liquidia Technologies, Inc. (NASDAQ:LQDA) has received an average consensus rating of "Buy" from ten brokerages, with an average price target of $32.11.
• The company reported a 141.5% increase in revenue year-over-year, despite missing earnings per share expectations, with a reported EPS of ($0.49).
• Recent insider activity includes significant stock sales, with Director Raman Singh selling 45,524 shares and CFO Michael Kaseta selling 30,000 shares in August and September.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) has been given an average rating of "Buy" by the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have given a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $32.1111.

A number of equities analysts have recently weighed in on LQDA shares. HC Wainwright upped their price target on shares of Liquidia Technologies from $29.00 to $35.00 and gave the stock a "buy" rating in a research note on Wednesday, May 28th. BTIG Research reiterated a "buy" rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. Bank of America reduced their target price on shares of Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. Scotiabank increased their target price on shares of Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a research note on Wednesday, May 28th. Finally, Wells Fargo & Company increased their target price on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a research note on Wednesday, August 13th.

Insiders Place Their Bets

In other Liquidia Technologies news, CFO Michael Kaseta sold 30,000 shares of Liquidia Technologies stock in a transaction on Tuesday, August 5th. The shares were sold at an average price of $20.00, for a total value of $600,000.00. Following the sale, the chief financial officer directly owned 376,412 shares in the company, valued at approximately $7,528,240. The trade was a 7.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paul B. Manning sold 328,268 shares of Liquidia Technologies stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $28.78, for a total transaction of $9,447,553.04. Following the sale, the director directly owned 430,828 shares of the company's stock, valued at $12,399,229.84. The trade was a 43.24% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 881,097 shares of company stock valued at $23,689,864 over the last quarter. Company insiders own 30.10% of the company's stock.

Institutional Trading of Liquidia Technologies

A number of institutional investors have recently bought and sold shares of the business. Cetera Investment Advisers increased its position in Liquidia Technologies by 4.3% during the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock worth $367,000 after purchasing an additional 1,277 shares in the last quarter. Bluefin Capital Management LLC bought a new stake in Liquidia Technologies during the 1st quarter worth approximately $250,000. Deutsche Bank AG increased its holdings in Liquidia Technologies by 53.4% during the 4th quarter. Deutsche Bank AG now owns 51,075 shares of the company's stock worth $601,000 after purchasing an additional 17,790 shares in the last quarter. Boothbay Fund Management LLC lifted its position in shares of Liquidia Technologies by 18.7% during the first quarter. Boothbay Fund Management LLC now owns 662,873 shares of the company's stock valued at $9,777,000 after purchasing an additional 104,215 shares in the last quarter. Finally, Millennium Management LLC bought a new position in shares of Liquidia Technologies during the fourth quarter valued at about $526,000. Institutional investors own 64.54% of the company's stock.

Liquidia Technologies Stock Down 3.6%

Shares of NASDAQ LQDA traded down $0.89 during midday trading on Thursday, reaching $23.78. 4,384,298 shares of the company's stock were exchanged, compared to its average volume of 2,224,081. Liquidia Technologies has a 52-week low of $9.71 and a 52-week high of $29.94. The stock has a market capitalization of $2.05 billion, a PE ratio of -13.99 and a beta of 0.22. The company has a debt-to-equity ratio of 9.84, a quick ratio of 2.41 and a current ratio of 2.49. The business's fifty day moving average price is $23.11 and its two-hundred day moving average price is $17.54.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.06). The firm had revenue of $8.84 million during the quarter, compared to the consensus estimate of $3.90 million. Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. Liquidia Technologies's quarterly revenue was up 141.5% compared to the same quarter last year. Analysts forecast that Liquidia Technologies will post -1.51 EPS for the current year.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).